Veenat Imatinib 400 Mg Tablets About
Veenat 400 Imatinib 400 Mg Tablets offer access to a grand advancement in targeted cancer therapy. Developed by Natco Pharma Ltd., these film-coated tablets deliver a precise 400 mg dose of Imatinib Mesylate-an essential option in scarce, high-purity tyrosine kinase inhibitors. Select Veenat 400 for its magnificent efficacy against Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST), and Ph+ Acute Lymphoblastic Leukemia (ALL), ensuring transcendent standards in patient care. Securely packaged in blister strips and available by prescription, Veenat 400 sets a new benchmark in oncology solutions.
Veenat 400: Who Uses, How It's Applied, and Its Distinct Features
Veenat Imatinib 400 Mg Tablets are chiefly used by individuals diagnosed with certain cancers, including CML, GIST, and Ph+ ALL. Administered orally, Veenat 400 ensures direct absorption and effective action at the site of application. This prescription-only medication features high purity and a film-coated finish that enhances ease of swallowing. Offered in precisely measured tablets, Veenat 400 exemplifies quality manufacturing from India's trusted supplier, making it an invaluable therapeutic choice in oncology.
Veenat 400: Sample Policy, Delivery, and Payment Terms
Veenat 400 comes securely packaged in blister strips within a cardboard box, protecting each tablet from moisture and light. For sample policy details, stock is readily available upon request for qualified buyers. Our logistics process ensures prompt delivery, typically within agreed timelines, ensuring treatments are never delayed. Flexible payment terms further streamline procurement, allowing seamless transactions for manufacturers, suppliers, traders, and healthcare facilities. Trust our efficient and reliable operations to meet your urgent and ongoing requirements.
FAQ's of Veenat Imatinib 400 Mg Tablets:
Q: How should Veenat Imatinib 400 Mg Tablets be administered?
A: Veenat 400 tablets should be taken orally with water, as directed by a physician. It is essential to follow the prescribed dosage and schedule for optimal therapeutic effect and safety.
Q: What are the main indications for Veenat 400?
A: Veenat 400 is primarily indicated for the treatment of Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST), and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
Q: When is Veenat 400 prescribed?
A: Veenat 400 is prescribed when a patient is diagnosed with eligible types of leukemia or certain tumors, and your oncologist determines that a tyrosine kinase inhibitor is necessary for treatment.
Q: Where should Veenat 400 tablets be stored?
A: Store Veenat 400 tablets below 25C in a dry place, protected from light and moisture, to preserve their potency and shelf life.
Q: What benefits does Veenat 400 offer over other treatments?
A: Veenat 400 offers targeted therapy, high-purity composition, and precise dosing, contributing to more effective cancer management with fewer side effects compared to some traditional treatments.
Q: How is Veenat 400 packaged for safe delivery?
A: Each tablet is securely sealed in a blister strip and placed in a robust cardboard box, ensuring safety, freshness, and protection during logistics and handling.